Laboratoires Euromedis Société anonyme Toekomstige groei
Future criteriumcontroles 0/6
Laboratoires Euromedis Société anonyme's earnings are forecast to decline at 79.6% per annum while its annual revenue is expected to grow at 2.1% per year. EPS is expected to decline by 79.9% per annum. Return on equity is forecast to be 5.6% in 3 years.
Belangrijke informatie
-79.6%
Groei van de winst
-79.9%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 15.4% |
| Inkomstengroei | 2.1% |
| Toekomstig rendement op eigen vermogen | 5.6% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 05 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues
Aug 14
Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?
Dec 12Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues
Jul 29Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?
Oct 05Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger
Jun 14Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive
Oct 03Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality
Jun 12Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?
Mar 18The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?
Feb 11Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 14
Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?
Dec 19Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)
Nov 22Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 39 | 2 | 1 | N/A | 1 |
| 12/31/2025 | 38 | 1 | 1 | N/A | 1 |
| 12/31/2024 | 36 | 1 | 6 | N/A | 1 |
| 12/31/2023 | 37 | 13 | N/A | N/A | N/A |
| 9/30/2023 | 43 | 4 | N/A | N/A | N/A |
| 6/30/2023 | 50 | -6 | -5 | -3 | N/A |
| 3/31/2023 | 52 | -6 | -4 | -2 | N/A |
| 12/31/2022 | 54 | -6 | -2 | -1 | N/A |
| 9/30/2022 | 62 | -7 | 6 | 8 | N/A |
| 6/30/2022 | 69 | -8 | 15 | 17 | N/A |
| 3/31/2022 | 91 | -3 | 16 | 18 | N/A |
| 12/31/2021 | 112 | 2 | 17 | 19 | N/A |
| 9/30/2021 | 158 | 13 | 8 | 9 | N/A |
| 6/30/2021 | 204 | 23 | -2 | -1 | N/A |
| 3/31/2021 | 199 | 23 | 6 | 6 | N/A |
| 12/31/2020 | 193 | 23 | 13 | 14 | N/A |
| 9/30/2020 | 147 | 12 | 13 | 14 | N/A |
| 6/30/2020 | 100 | 0 | 13 | 14 | N/A |
| 3/31/2020 | 89 | -2 | 5 | 7 | N/A |
| 12/31/2019 | 77 | -4 | -2 | -1 | N/A |
| 12/31/2018 | 76 | -5 | -3 | -2 | N/A |
| 1/31/2018 | 76 | -1 | 0 | 1 | N/A |
| 10/31/2017 | 75 | -1 | N/A | 1 | N/A |
| 7/31/2017 | 74 | 0 | N/A | 1 | N/A |
| 4/30/2017 | 74 | 1 | N/A | 1 | N/A |
| 1/31/2017 | 74 | 1 | N/A | 0 | N/A |
| 10/31/2016 | 74 | 1 | N/A | 1 | N/A |
| 7/31/2016 | 74 | 1 | N/A | 1 | N/A |
| 4/30/2016 | 73 | 2 | N/A | 3 | N/A |
| 1/31/2016 | 72 | 2 | N/A | 5 | N/A |
| 10/31/2015 | 72 | 2 | N/A | 4 | N/A |
| 7/31/2015 | 72 | 2 | N/A | 3 | N/A |
| 4/30/2015 | 71 | 2 | N/A | 2 | N/A |
| 1/31/2015 | 71 | 2 | N/A | 1 | N/A |
| 10/31/2014 | 72 | 2 | N/A | 2 | N/A |
| 7/31/2014 | 72 | 3 | N/A | 3 | N/A |
| 4/30/2014 | 74 | 3 | N/A | 3 | N/A |
| 1/31/2014 | 75 | 2 | N/A | 3 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: ALEMG's earnings are forecast to decline over the next 3 years (-79.6% per year).
Winst versus markt: ALEMG's earnings are forecast to decline over the next 3 years (-79.6% per year).
Hoge groeiwinsten: ALEMG's earnings are forecast to decline over the next 3 years.
Omzet versus markt: ALEMG's revenue (2.1% per year) is forecast to grow slower than the French market (5.6% per year).
Hoge groei-inkomsten: ALEMG's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: ALEMG's Return on Equity is forecast to be low in 3 years time (5.6%).